For Type 1 Diabetes, Teplizumab (Tzield) Preserves Beta Cell Function and Shows Significant Other Benefits
The preservation of insulin-producing beta cells is just one of the benefits of teplizumab, also known as Tzield, a phase 3 trial shows.
Source: yale.edu